<DOC>
	<DOC>NCT01259804</DOC>
	<brief_summary>Open pilot study of peanut oral immunotherapy in 22 children with peanut allergy</brief_summary>
	<brief_title>Study of Tolerance to Oral Peanut</brief_title>
	<detailed_description>Background Peanut allergy is severe and rarely resolves. Objective To test the efficacy and safety of a new oral immunotherapy protocol for peanut allergy. Method 22 peanut-allergic children will undergo oral challenge. Oral immunotherapy will be administered by gradual updosing with 2-weekly increments (8-38w) to 800mg protein (5 peanuts/day) followed by 30-weeks maintenance. Oral challenge will be repeated after 6 and 30 weeks maintenance.</detailed_description>
	<mesh_term>Peanut Hypersensitivity</mesh_term>
	<criteria>Peanut allergy defined by oral challenge Major immunodeficiency</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>peanut</keyword>
	<keyword>food allergy</keyword>
	<keyword>anaphylaxis</keyword>
	<keyword>immunotherapy</keyword>
</DOC>